SHA:600812 Market Cap

SHA:600812 has a market cap or net worth of 10.31 billion as of March 9, 2026. Its market cap has increased by 4.16% in one year.

Market Cap

10.31B

Enterprise Value

21.01B

Revenue

9.79B

Ranking

n/a

PE Ratio

56.72

Stock Price

5.82

Market Cap Chart

Since August 28, 2006, SHA:600812's market cap has increased from 2.00B to 10.31B, an increase of 416.76%. That is a compound annual growth rate of 8.77%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	9.47B	-0.18%
Dec 31, 2025	9.49B	6.96%
Dec 31, 2024	8.87B	-9.30%
Dec 29, 2023	9.78B	-10.94%
Dec 30, 2022	10.98B	-46.31%
Dec 31, 2021	20.45B	21.87%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Yahong Meditech	9.44B
Changzhou Qianhong Biopharma CO.,LTD	9.54B
Chongqing Taiji Industry(Group) Co.,Ltd	9.30B
Shandong Lukang Pharmaceutical	9.27B
KPC Pharmaceuticals,Inc.	9.11B
Zhejiang Xianju Pharmaceutical	9.02B
Shenzhen Neptunus Bioengineering	8.84B
Harbin Pharmaceutical Group	8.79B

Market Cap Rankings